Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Terminated Phase 3 Interventional Results available

Extension Study of Pimavanserin in Subjects With Major Depressive Disorder and Inadequate Response to Antidepressant Treatment

ClinicalTrials.gov ID: NCT04000009

Public ClinicalTrials.gov record NCT04000009. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 16, 2026, 8:49 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A 52-Week Open-Label Extension Study of Pimavanserin in Subjects With Major Depressive Disorder and Inadequate Response to Antidepressant Treatment

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

To assess the safety and tolerability of long-term pimavanserin treatment in subjects with major depressive disorder and inadequate response to antidepressant treatment.

Study identification

NCT ID
NCT04000009
Recruitment status
Terminated
Study type
Interventional
Phase
Phase 3
Lead sponsor
ACADIA Pharmaceuticals Inc.
Industry
Enrollment
235 participants

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jun 6, 2019 (Actual)
Primary completion
Feb 22, 2021 (Actual)
Completion
Feb 22, 2021 (Actual)
Last update posted
Apr 5, 2022

2019 – 2021

United States locations

U.S. sites
33
U.S. states
15
U.S. cities
29
Facility City State ZIP Site status
CNS Network Garden Grove California 90806 —
Behavioral Research Specialists Glendale California 91206 —
Irvine Clinical Research Irvine California 92614 —
Synergy San Diego Lemon Grove California 91945 —
Pacific Research Partners, LLC Oakland California 94607 —
NRC Research Institute Orange California 92868 —
MCB Clinical Research centers, LLC Colorado Springs Colorado 80910 —
Clinical Neuroscience Solutions ( CNS Healthcare)-Jacksonville Jacksonville Florida 32256 —
Meridien Research Maitland Florida 32751 —
Florida Research Center, Inc. Miami Florida 33174 —
CNS Health Care (Orlando) Orlando Florida 32801 —
Emory University School of Medicine Atlanta Georgia 30322 —
Synexus Clinical Research Atlanta Georgia 30328 —
Great Lakes Clinical Trials Chicago Illinois 60640 —
Capstone Clinical Research Libertyville Illinois 60048 —
Collective Medical Research, LLC Prairie Village Kansas 66208 —
Adams Clinical Watertown Massachusetts 02472 —
Integrative Clinical Trials Brooklyn New York 11229 —
Social Psychiatry Research Institute (SPRI) Brooklyn New York 11235 —
Department of Psychiatry, Icahn School of Medicine at Mount Sinai New York New York 10029 —
The Medical Research Network, LLC New York New York 10128 —
Finger Lakes Clinical Research Rochester New York 14618 —
Charak Clinical Research Center Garfield Heights Ohio 44125 —
Summit Research Network (Oregon) Inc. Portland Oregon 97210 —
University of Pennsylvania Philadelphia Pennsylvania 19104 —
Coastal Carolina Research Center Mt. Pleasant South Carolina 26464 —
Clinical Neuroscience Solutions CNS Healthcare Memphis Tennessee 38119 —
Research Strategies of Memphis, LLC Memphis Tennessee 38119 —
Future Search Trials of Dallas Dallas Texas 75231 —
Baylor College of Medicine Houston Texas 77030 —
Clinical Trials of Texas, Inc. San Antonio Texas 78229 —
Grayline Research Center Wichita Falls Texas 76309 —
IPC Research Waukesha Wisconsin 53188 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 38 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT04000009, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Apr 5, 2022 · Synced Oct 16, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT04000009 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →